The antibodies and the single-strand variable fragment antibodies in the cerebrospinal fluid of MS patients were immunoreactive to GAPDH, suggesting that GAPDH could promote the proliferation of B cells in the central nervous system in MS patients [9, 10]. This evidence concerns the gene GAPDH and myeloid sarcoma.